Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33241639

about

Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.Characterization of adipose-derived stem cells of anatomical region from mice Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer.A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature Early development of sunitinib in hepatocellular carcinoma.Developing better treatments in hepatocellular carcinoma.Endoglin-targeted cancer therapy.Endoglin for tumor imaging and targeted cancer therapy.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Understanding and targeting resistance to anti-angiogenic therapies.Endoglin for targeted cancer treatment.Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma.Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth.Local effects of retrovirally transduced endostatin-expressing human umbilical cord blood CD34+ cells on transplanted malignancy in a mouse model of hepatic cancer.Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential.Endoglin - a marker of vascular endothelial cell proliferation in cancer.AIB1 as an independent prognostic marker in hepatocellular carcinoma after hepatic resection.Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.

P2860

Q26853543-9E5D09BC-5FB9-4154-A333-515A1765AFE7 Q33286433-227BC948-490C-4727-9A5E-F465741E7B32 Q33289829-B40733B7-DB9F-4C84-9767-EECBDF205EFC Q33705264-79B99B8A-44E8-42CA-A1A9-DBFF6B20CDA4 Q33843943-D075AADE-F74E-40F0-9279-5AAB95B1C563 Q34143870-CB987733-3E23-45DA-9ECE-33F167644080 Q34606259-27461925-C592-44E9-9D22-7B9EF40F91E6 Q34783772-88D29A64-17E0-42E1-B644-5D5DD15FD992 Q35007692-4A38C950-C61B-44AE-8858-5B3B54F4058E Q35089199-91C3BFCF-9088-4E99-85C1-D2829E6DE670 Q36061812-DC83DDFB-519E-4840-827D-0E9E844A6D93 Q36223538-D7262B7D-70FC-4EAF-97A9-C91AC25C0E1D Q37020248-96BB940D-3CFE-4D12-86E5-E9F17CAAB646 Q37357314-1CBAD5D7-E7AE-4A5A-B7B0-949F34C2218C Q37798817-AF2B1AEE-0730-4C13-AB7F-AE1ED25D93A3 Q37804900-3CE71C59-9D67-48D7-B82E-BD839DE9A145 Q38074721-1A7882D0-B242-4E50-A575-FDD7D4D73AE6 Q38078237-CBAAB0AF-5452-42A4-9AE9-09F1EA43D4A9 Q38133568-E33F2346-02BB-4F43-8C16-B3573EF4C9C8 Q38180309-8A9F518A-A737-4595-B1E5-92D20356EAB7 Q38962280-04667430-112C-4AA9-A5CC-B03B7AD93027 Q38965801-BADBD956-C223-471D-A925-7593C2CA3077 Q39907064-EE5CAFF9-75F6-4866-B8AF-28D0F2AC12FD Q40013239-29572E57-3CEF-4BDA-8EE7-FD7E676CA3A7 Q43121223-985C18B4-9D8E-438B-8626-CEEE36B9506C Q43889780-A0CD6142-DCC8-4FE3-8B79-C6E96C035C76 Q47229175-FBC441F4-4ACC-4034-95E3-06B65588928B Q53616024-A70EA071-39D2-4ED5-B6D0-A5F778DD71F3

P2860

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33241639

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@ast

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@en

type

label

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@ast

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@en

prefLabel

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@ast

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@en

P1433

Q33241639-E88D1A88-CEB5-496C-86C3-E74F77E7552F

P1476

Q33241639-5FAD206D-29BA-4C1D-82B1-97C5339B6DC6

P2093

Q33241639-32880349-20BD-4365-A94C-BB359C414547

Q33241639-9CD5CBC5-1B3C-454E-BC85-9FB1D1FA5150

Q33241639-B1142A5E-990D-4DAC-9405-3BE33D1901F3

Q33241639-CA3D13AA-485C-47BD-8DCD-F1132814D1EB

P2860

Q33241639-04685FDD-2F0E-4AB7-868C-8DABA266DBE2

Q33241639-0D6B07AF-76D2-4386-93D4-AB43A3EC0FDD

Q33241639-11432605-10F3-44EE-9785-ABD4A74DA9CA

Q33241639-116BEDEC-DF56-487F-BA2B-BB2FC44B0884

Q33241639-128C5757-BB6F-4A54-9FBB-FB17D6AE9B23

Q33241639-178F0CCC-A3A4-40A3-890F-78D90B452B83

Q33241639-28449D3B-57E1-455A-8897-F145C72D9EF5

Q33241639-33FD6931-96D1-4FF3-AA7D-31717016123C

Q33241639-387CD349-B09E-437F-AD20-6C37BA3B7FF5

Q33241639-3B134262-556D-47BE-9847-33BE792327D2

P2888

Q33241639-743E834D-3BF4-44A4-B223-2B8F4852F857

P304

Q33241639-AD197BAB-5D50-4F56-A409-897AA59BC545

P31

Q33241639-ACAE0D52-37A5-4E79-A9F7-F335A65E97EB

P356

Q33241639-BD6788C9-E285-4D4F-92F1-932A865FB783

P407

Q33241639-89C2FC98-C989-4BD6-9ABC-BE4CD4ABB002

P478

Q33241639-9C3D0140-1007-4E27-9733-13EF1BFB043C

P577

Q33241639-FC53C0F3-F94D-4FE5-9F40-F5F9E71CE76A

P5875

Q33241639-2AF34279-900B-4CC5-9E30-571D833CAF6A

P6179

Q33241639-F00F1246-7896-4617-8284-425B17226A2E

P698

Q33241639-5229D28F-4C16-40B4-B2D0-2A530A7ABFA4

P932

Q33241639-89C73D59-0EE3-431C-91AA-221A37E3853C

P356

1471-2407-6-110

P1433

P1476

Correlation between CD105 expr ...... s of hepatocellular carcinoma.

@en

P2093

Geng-wen Huang

http://www.w3.org/2001/XMLSchema#string

Lian-yue Yang

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Wei-qun Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies

Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma

Defective angiogenesis in mice lacking endoglin

CD105 is important for angiogenesis: evidence and potential applications

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Vascular-specific growth factors and blood vessel formation

Active drug targeting with immunoconjugates to choroidal neovascularization.

The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression.

Moving toward an understanding of the metastatic process in hepatocellular carcinoma.

P2888

1471-2407-6-110

P304

110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-6-110

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7131661

http://www.w3.org/2001/XMLSchema#string

P6179

1023507764

http://www.w3.org/2001/XMLSchema#string

P698

16650286

http://www.w3.org/2001/XMLSchema#string

P932

1475877

http://www.w3.org/2001/XMLSchema#string